Document Detail


Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
MedLine Citation:
PMID:  11511819     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To determine incidence, progression, and regression rates for abnormal cervical cytology and their correlates among women with HIV. METHODS: In a multicenter prospective cohort study conducted October 1, 1994, through September 30, 1999 at university, public, and private medical centers and clinics, 1639 HIV-seropositive and 452 seronegative women were evaluated every 6 months for up to 5 years using history, cervical cytology, T-cell subsets, and quantitative plasma HIV RNA. Human papillomavirus (HPV) typing at baseline was determined by polymerase chain reaction. Cytology was read using the Bethesda system, with any smear showing at least atypia considered abnormal. Poisson regression identified factors associated with incident cytologic abnormalities whereas logistic regression identified those associated with progression and regression after an abnormality. RESULTS: At least one abnormal smear was found during all of follow-up among 73.0% of HIV-seropositive patients and 42.3% of seronegatives (p <.001). Only 5.9% of seropositives ever developed high-grade lesions, and the proportion with high-grade findings did not rise over time. Incidence of atypical squamous cells of uncertain significance (ASCUS) or more severe lesions among HIV-seropositive patients and seronegative patients was 26.4 and 11.0/100 woman-years (rate ratio [RR], 2.4; 95% confidence interval [CI], 1.9-3.0), whereas that of at least low-grade squamous intraepithelial lesions (SIL) was 8.9 and 2.2/100 (RR, 4.0; CI, 2.6-6.1). HIV status, detection of the presence of human papillomavirus (HPV), CD4 lymphocyte count, and HIV RNA level predicted incidence of abnormal cytology (p <.05); HPV detection and HIV RNA level predicted progression (p <.01); and HPV detection, CD4 lymphocyte count, and HIV RNA level predicted regression (p <.001). Rates of incidence, progression, and regression of abnormal cytology did not differ between HIV seronegative women and seropositive women with CD4 lymphocyte counts >200/mm(3) and HIV RNA levels <4000/ml of similar HPV status. CONCLUSIONS: Although HIV infected women were at high risk for abnormal cytology, high-grade changes were uncommon. HIV status, HPV detection, CD4 lymphocyte count, and HIV RNA level predicted the incidence of cervical cytologic abnormalities. Progression was significantly increased only among the most immunosuppressed women, while regression was significantly reduced in all HIV seropositive women except those with the best controlled HIV disease.
Authors:
L S Massad; L Ahdieh; L Benning; H Minkoff; R M Greenblatt; H Watts; P Miotti; K Anastos; M Moxley; L I Muderspach; S Melnick
Related Documents :
10976619 - Women living with hiv: disclosure, violence, and social support.
21916839 - Hiv shedding in cervico-vaginal secretions in pregnant women.
8887189 - Colposcopic biopsies versus loop electrosurgical excision procedure cone histology in h...
21453549 - Clinical characteristics and risk factors of sporadic hepatitis e in central china.
7910799 - Treatment with interferon for genital hpv in hiv-positive and hiv-negative women.
2216549 - Maternal and perinatal issues regarding hiv infection.
17694939 - Case report of hantavirus pulmonary syndrome and review.
20003899 - Hiv/sti co-infection among men who have sex with men in spain.
15226169 - A randomized trial of chinese herbal medicines for the treatment of symptomatic hepatit...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  27     ISSN:  1525-4135     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-08-20     Completed Date:  2001-09-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  432-42     Citation Subset:  IM; X    
Affiliation:
Division of Gynecologic Oncology, Dept. of Obstetrics & Gynecology, Cook County Hospital, 1835 West Harrison Street, Chicago, IL 60612, USA. lsmassad@ameritech.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
CD4 Lymphocyte Count
Cervical Intraepithelial Neoplasia / complications,  diagnosis,  epidemiology*
Cohort Studies
Disease Progression
Female
HIV Infections / complications*
HIV-1 / isolation & purification
Humans
Incidence
Papillomaviridae / isolation & purification
Papillomavirus Infections / complications,  diagnosis,  epidemiology*
Population Surveillance
Prognosis
Prospective Studies
RNA, Viral / blood
Risk Factors
Tumor Virus Infections / complications,  diagnosis,  epidemiology*
Uterine Cervical Diseases / diagnosis,  epidemiology*
Vaginal Smears*
Grant Support
ID/Acronym/Agency:
U01-AI-31834/AI/NIAID NIH HHS; U01-AI-34993/AI/NIAID NIH HHS; U01-AI-34994/AI/NIAID NIH HHS; U01-AI-35004/AI/NIAID NIH HHS; U01-AI-42590/AI/NIAID NIH HHS; U01-HD-32632/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/RNA, Viral

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.
Next Document:  Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple ...